HOTLINE 24/7/365 UK: +44 (0) 1483 212150

GMP Expertise

The quality of the medicines, cosmetics, vaccines, biologics and other products produced by a Company, throughout the entire process, from the post-marketing, pre-clinical and clinical phases is paramount to its success.

Regulatory Agencies have zero tolerance to product defects as a result of poor quality.  The expectation is for products to reach the highest standards of purity and conformance to specification. This requires accurate and thorough testing of all materials used to produce the final finished form of the product.

During the clinical trial phase, the final ‘post-marketing production batch size’ may not have been finalised.  The scaling up of the batch sizes can potentially result in quality issues.  The processes involved have to be considered and documented fully in terms of what was done to test the stability of the product quality during production, no matter what the batch size.

PharSafer® partners with experienced GMP and GLP Companies in this area.  They all have the key experience and audit skills for potential Regulatory Inspections, meaning that they can carry out audits of manufacturing sites to ensure they are suitable and prepared for a Regulatory Inspection.

PharSafer® Tweets

We are excited to attend @IGPP_'s NHS Long Term Plan Conference 2023 in London Tomorrow! Don't forget to join us f… t.co/86xCvAIkPs

Read on Twitter...

Excited to attend the NHS Long Term Plan Conference 2023 in London next week! Join our CEO's talk on 'Enhancing P… t.co/awIq5nPidB

Read on Twitter...

All set and ready to go for Safety in Beauty #London 2023! Certainly not one to miss, be sure to attend our CEO D… t.co/6fB7uiXMS6

Read on Twitter...